HER-2 amplification evaluated by fluorescence in-situ hybridization (FISH) as a predictive marker in node-positive (N+) breast cancer (BC) patients (pts) randomly treated with CMF or an anthracycline-based therapy
- 30 April 2001
- journal article
- abstracts
- Published by Elsevier in European Journal Of Cancer
- Vol. 37, S270
- https://doi.org/10.1016/s0959-8049(01)81489-1